Nicole D. Perry - 02 Aug 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Vice President - Accounting
Signature
/s/ David Watson, attorney-in-fact for Nicole Perry
Issuer symbol
APLS
Transactions as of
02 Aug 2021
Net transactions value
-$60,230
Form type
4
Filing time
03 Aug 2021, 16:23:59 UTC
Previous filing
02 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $3,760 +1,000 +21% $3.76* 5,847 02 Aug 2021 Direct F1
transaction APLS Common Stock Sale $63,990 -1,000 -17% $63.99 4,847 02 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -1,000 -14% $0.000000 6,161 02 Aug 2021 Common Stock 1,000 $3.76 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled exercise from a 10B5-1 trading plan.
F2 This option was granted on July 31, 2015 and is fully vested.